An Iowa Medicaid billing change the state says is required by federal law is drawing sharp criticism from pediatric therapy ...

New procedural codes establish standardized pathway for clinical use of autologous heterogeneous skin construct across care ...

By unilaterally gutting the U.S. childhood vaccination schedule, President Donald Trump and Health and Human Services ...

Meta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and ...

Meta Platforms leads today???s Zacks Research Daily as AI-driven engagement and ad demand fuel growth, even as heavy AI ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

In 2026, residents in Virginia, Maryland, and Washington, D.C., will see significant changes as a range of new laws go into ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

An upcoming adjustment to how much behavioral health providers get paid through Oregon’s Medicaid infrastructure could put some, specifically occupational therapists, straight out of business.

How can pediatric hospitalists improve critical-care billing and documentation for hospitalized pediatric patients?